Cargando…

Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION—A phase 4, multinational, randomized, double-blind, placebo-controlled study

INTRODUCTION: Migraine is a highly prevalent and disabling neurological disease. Excessive use of acute medications can lead to medication-overuse headache (MOH), occurring when a patient experiences an increasing number of headache and migraine days, despite taking greater amounts of acute medicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensen, Rigmor H., Schytz, Henrik Winther, Tassorelli, Cristina, Terwindt, Gisela M., Carlsen, Louise N., Mittoux, Aurélia, Østerberg, Ole, Lipton, Richard B., Tepper, Stewart J., Blumenfeld, Andrew, Lundqvist, Christofer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994537/ https://www.ncbi.nlm.nih.gov/pubmed/36908606 http://dx.doi.org/10.3389/fneur.2023.1114654

Ejemplares similares

Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab
por: Limberg, Nicole
Publicado: (2023)

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache
por: Marmura, Michael J., et al.
Publicado: (2021)

Medication-overuse headache: a review
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2014)

Eptinezumab for migraine
Publicado: (2022)

Eptinezumab for migraine prevention in patients 50 years or older
por: Martin, Vincent, et al.
Publicado: (2022)

Severity of Analgesic Dependence and Medication-overuse Headache
por: Lundqvist, Christofer, et al.
Publicado: (2019)

Telephone follow‐up on treatment and patient satisfaction at a Danish tertiary headache center: A prospective study
por: Carlsen, Louise Ninett, et al.
Publicado: (2022)

Effectiveness and Safety of Eptinezumab in Episodic and Chronic Migraine Headache in the UAE: A Retrospective Study
por: Bader, Yazan, et al.
Publicado: (2023)

A Review of Eptinezumab Use in Migraine
por: Datta, Abhigyan, et al.
Publicado: (2021)

Risk of medication overuse headache across classes of treatments for acute migraine
por: Thorlund, Kristian, et al.
Publicado: (2016)

Disability caused by medication-overuse headache can be considerably reduced by detoxification. Results from multinational COMOESTAS study
por: Bendtsen, L, et al.
Publicado: (2013)

Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2
por: Lipton, Richard B., et al.
Publicado: (2020)

GPs’ experiences with brief intervention for medication-overuse headache: a qualitative study in general practice
por: Frich, Jan C, et al.
Publicado: (2014)

In-patient/out-patient detoxification is highly effective in Medication Overuse Headache: report from a multicentric, multinational study
por: Tassorelli, C, et al.
Publicado: (2013)

Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
por: Pijpers, Judith A, et al.
Publicado: (2020)

Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study
por: Find, Ninett Louise, et al.
Publicado: (2016)

Myofascial trigger points in migraine and tension-type headache
por: Do, Thien Phu, et al.
Publicado: (2018)

EHMTI-0327. Information and communication technology for improving the management of medication overuse headache: results of the comoestas multicentric, multinational study
por: Tassorelli, C, et al.
Publicado: (2014)

Feasibility of a brief intervention for medication-overuse headache in primary care – a pilot study
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2014)

Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society
por: Diener, Hans Christoph, et al.
Publicado: (2021)

Debate: Are cluster headache and migraine distinct headache disorders?
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2022)

Clinical and Demographical Characteristics of Patients with Medication Overuse Headache in Argentina and Chile: Analysis of the Latin American Section of COMOESTAS Project
por: Shand, Beatriz, et al.
Publicado: (2015)

Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab
por: Blumenfeld, Andrew, et al.
Publicado: (2022)

Reduction in migraine-associated burden after eptinezumab treatment in patients with chronic migraine
por: McAllister, Peter, et al.
Publicado: (2022)

Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache
por: Gaul, Charly, et al.
Publicado: (2011)

Chronic migraine plus medication overuse headache: two entities or not?
por: Negro, Andrea, et al.
Publicado: (2011)

Withdrawal failure in patients with chronic migraine and medication overuse headache
por: D’Amico, Domenico, et al.
Publicado: (2021)

Medication Overuse Headaches among Children—The Contribution of Migraine and TTH
por: Genizi, Jacob, et al.
Publicado: (2023)

Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab
por: Scuteri, Damiana, et al.
Publicado: (2021)

Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial
por: Pijpers, Judith A., et al.
Publicado: (2022)

Medication-Overuse Headache: Differences between Daily and Near-Daily Headache Patients
por: Krymchantowski, Abouch V., et al.
Publicado: (2016)

Temperament and character profiles of patients with chronic migraine and medication-overuse headache
por: Watanabe, Y, et al.
Publicado: (2013)

Migraine-specific quality of life questionnaire and relapse of medication overuse headache
por: Caproni, Stefano, et al.
Publicado: (2015)

Effects of smartphone overuse on headache, sleep and quality of life in migraine patients
por: Demir, Yasemin P., et al.
Publicado: (2019)

Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study
por: Cowan, Robert P., et al.
Publicado: (2022)

Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial
por: Ashina, Messoud, et al.
Publicado: (2023)

Traumatic Experiences, Stressful Events, and Alexithymia in Chronic Migraine With Medication Overuse
por: Bottiroli, Sara, et al.
Publicado: (2018)

Study protocol: Brief intervention for medication overuse headache - A double-blinded cluster randomised parallel controlled trial in primary care
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2012)

Patient‐identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient‐centered outcome
por: Lipton, Richard B., et al.
Publicado: (2021)

Interrelations between migraine-like headache and persistent post-traumatic headache attributed to mild traumatic brain injury: a prospective diary study
por: Ashina, Håkan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g1rb1vs3qvnku0srnnhgujeh0e